US News

Pfizer vaccine protecting against hospitalisation during Omicron wave – study

Published by

JOHANNESBURG (Reuters) – Two doses of Pfizer-BioNTech’s COVID-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major real-world study on the potential impact of Omicron showed on Tuesday, as the country battles a spike in infections linked to the new variant. The study released by South Africa’s largest private health insurance administrator, Discovery Health, was based on more than 211,000 positive COVID-19 test results from Nov. 15 to Dec. 7, around 78,000 of which were attributed to Omicron. The 78,000 results are not confirmed Omicro…

Read More

Facebook Comments

Check Also

Elon Musk: Tesla Bot Is The Most Important Project For Tesla This Year

During Tesla Inc (NASDAQ:TSLA)’s fourth-quarter earnings call, CEO ...